Vincent Tapia
Physician Assistant · Casa Grande, AZNPI 1255560710
Payments from drug & device makers
Across 288 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$631
- AstraZeneca$501
- Novo Nordisk$453
- Amgen$274
- Otsuka America Pharmaceutical, Inc.$225
- Lilly USA, LLC$221
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,760100%
- Entertainment$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $631 |
| AstraZeneca | 17 | $501 |
| Novo Nordisk | 37 | $453 |
| Amgen | 16 | $274 |
| Otsuka America Pharmaceutical, Inc. | 10 | $225 |
| Lilly USA, LLC | 13 | $221 |
| GSK | 12 | $203 |
| Abbott | 11 | $180 |
| Teva Pharmaceuticals USA, Inc. | 8 | $151 |
| Sunovion Pharmaceuticals Inc. | 8 | $146 |
| Mylan Specialty L.p. | 8 | $140 |
| Sumitomo Pharma America, Inc. | 5 | $139 |
| Sanofi-aventis U.S. LLC | 7 | $137 |
| Eisai Inc. | 5 | $130 |
| Exact Sciences | 7 | $124 |
| Novartis | 6 | $117 |
| Bayer | 8 | $116 |
| Radius Health, Inc. | 5 | $110 |
| Astellas Pharma US Inc | 5 | $96 |
| Amarin Pharma, Inc. | 6 | $84 |
| Johnson & Johnson | 5 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Lucid Diagnostics Inc. | 2 | $51 |
| Pfizer | 3 | $44 |
| Dexcom, Inc. | 2 | $44 |
| Viatris Specialty LLC | 2 | $43 |
| Esperion Therapeutics, Inc. | 3 | $39 |
| Averitas Pharma Inc. | 1 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Corcept Therapeutics | 1 | $19 |
| Optos, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,778 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $79,730 |
| EliquisApixaban | 47 | $50,395 |
| XareltoRivaroxaban | 48 | $44,370 |
| VraylarCariprazine Hcl | 26 | $43,197 |
| JardianceEmpagliflozin | 34 | $29,681 |
| MyrbetriqMirabegron | 32 | $22,087 |
| GemtesaVibegron | 35 | $21,185 |
| FarxigaDapagliflozin Propanediol | 36 | $18,421 |
| JanuviaSitagliptin Phosphate | 12 | $18,416 |
| MounjaroTirzepatide | 13 | $13,584 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 14 | $12,590 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $11,270 |
| NexlizetBempedoic Acid/Ezetimibe | 21 | $9,173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 174 | $7,635 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 130 | $3,624 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Levemir | $453 | $82,23069 claims |
| PfizerEliquis | $44 | $50,39547 claims |
| Johnson & JohnsonXarelto | $72 | $44,37048 claims |
| AbbVieVraylar, Synthroid | $631 | $44,24861 claims |
| Astellas Pharma US IncMyrbetriq | $96 | $22,08732 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $139 | $21,18535 claims |
| AstraZenecaFarxiga | $501 | $18,42136 claims |
| Lilly USA, LLCMounjaro | $221 | $13,58413 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $137 | $12,59014 claims |
| GSKAnoro Ellipta | $203 | $11,27024 claims |
| Esperion Therapeutics, Inc.Nexlizet | $39 | $9,17321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Casa Grande
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
- Micah LasleyPhoenix$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.